How to manage the difficult-to-treat dyspeptic patient

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 4, Issue 1, 2007, Pages 35-42

  Talley, Nicholas J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Dyspepsia; Functional dyspepsia; H. pylori; Nonulcer dyspepsia; Proton pump inhibitors

Indexed keywords

ACARBOSE; AMITRIPTYLINE; ANTIBIOTIC AGENT; BISMUTH; BUSPIRONE; CISAPRIDE; DESIPRAMINE; DIGOXIN; DOMPERIDONE; ESOMEPRAZOLE; IRON; METOCLOPRAMIDE; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PLACEBO; POTASSIUM; PROKINETIC AGENT; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SUMATRIPTAN; TEGASEROD; TETRACYCLINE; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL EXAMINATION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIGESTIVE SYSTEM CANCER; DRUG MEGADOSE; DRUG TREATMENT FAILURE; DYSPEPSIA; ELECTROSTIMULATION THERAPY; ENDOSCOPY; EPIGASTRIC PAIN; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL MOTILITY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IRRITABLE COLON; LOW DRUG DOSE; META ANALYSIS; NAUSEA AND VOMITING; NONHUMAN; PATIENT EDUCATION; PEPTIC ULCER; PRIORITY JOURNAL; PSYCHOTHERAPY; RELAXATION TRAINING; REPEAT PROCEDURE; REVIEW; SATIETY; STOMACH EMPTYING; STOMACH PARESIS; STOMACH SCINTISCANNING; SYSTEMATIC REVIEW; TREATMENT PLANNING;

ADULT; DIAGNOSIS, DIFFERENTIAL; DYSPEPSIA; FEMALE; HUMANS; TREATMENT FAILURE;

EID: 33846043903     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep0685     Document Type: Review

References (32)

1. Camilleri M et al. (2005) Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: Results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol 3: 543-552
2. Ahlawat et al. (2005) Dyspepsia consulters and patterns of management: A population-based study. Aliment Pharmacol Ther 22: 251-259
3. Tack J et al. (2005) Prevalence of acid reflux in functional dyspepsia and its association with symptom profile. Gut 54: 1370-1376
4. Talley NJ and Vakil N (2005) Practice Parameters Committee of the American College of Gastroenterology. Guidelines for the management of dyspepsia. Am J Gastroenterol 100: 2324-2337
5. Thomson AB et al. (2003) The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: The Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study. Aliment Pharmacol Ther 17: 1481-1491
6. Numans ME et al. (2004) Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: A meta-analysis of diagnostic test characteristics. Ann Intern Med 140: 518-527
7. Zerbib F et al. (2006) Esophageal pH-impedance monitoring and symptom analysis in GERD: A study in ptients off and on therapy. Am J Gastroenterol 101: 1956-1963
8. Solaymani-Dodaran M et al. (2005) Mortality associated with Barrett's esophagus and gastroesophageal reflux disease diagnoses - a population-based cohort study. Am J Gastroenterol 100: 2616-2621
9. Talley NJ et al. (2005) AGA technical review on the evaluation of dyspepsia. Gastroenterology 129: 1756-1780
10. Chitkara D et al. (2005) Aerophagia in adults: A comparison with functional dyspepsia. Aliment Pharmacol Ther 22: 855-858
11. McNamara D et al. (2002) Does Helicobacter pylori eradication affect symptoms in nonulcer dyspepsia: A 5-year follow-up study. Helicobacter 7: 317-321
12. Malfertheiner P et al. (2002) Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 16: 167-180
13. Moayyedi P et al. (2004) The efficacy of proton pump inhibitors in non-ulcer dyspepsia: A systematic review and economic analysis. Gastroenterology 127: 1329-1337
14. Moayyedi P and Talley NJ (2006) Gastro-oesophageal reflux disease. Lancet 367: 2086-2100
15. Van Zanten SV et al. (2006) Esomeprazole 40 mg once a day in patients with functional dyspepsia: The randomized, placebo-controlled "ENTER" trial. Am J Gastroenterol 101: 2096-2106
16. Tack J et al. (2006) Functional gastroduodenal disorders. Gastroenterology 130: 1466-1479
17. Talley NJ et al. (2006) Functional dyspepsia, delayed gastric emptying and impaired quality of life. Gut 55: 933-939
18. Camilleri M and Talley NJ (2004) Pathophysiology as a basis for understanding symptom complexes and therapeutic targets. Neurogastroenterol Motil 16: 135-142
19. Tack J et al. (1998) Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 115: 1346-1352
20. Tack J et al. (2004) Pathophysiology and treatment of functional dyspepsia. Gastroenterology 127: 1239-1255
21. Delgado-Aros S et al. (2004) Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia. Gastroenterology 127: 1685-1694
22. De Schepper HU et al. (2004) Assessment of gastric accommodation: overview and evaluation of current methods. Neurogastroenterol Motil 16: 275-285
23. Tack J et al. (2003) Assessment of meal induced gastric accommodation by a satiety drinking test in health and in severe functional dyspepsia. Gut 52: 1271-1277
24. Veldhuyzen van Zanten SJ et al. (2005) A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in Helicobacteri pylori negative, primary care patients with dyspepsia: The CADET-HN Study. Am J Gastroenterol 100: 1489-1490
25. Tack J and Kindt S (2005) Pathogenesis and therapy for idiopathic dyspepsia. Curr Gastroenterol Rep 7: 437-444
26. Holtmann G et al. (2006) A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med 354: 832-840
27. Lin Z et al. (2006) Sympton responses, long-term outcomes and adverse events beyond 3 years of high-frequency gastric electrical stimulation for gastroparesis. Neurogastroenterol Motil 18: 18-27
28. Talley NJ et al. (2006) Double-blind, randomized, placebo-controlled study to evaluate the effects of tegaserod on gastric motor, sensory and myoelectric function in healthy volunteers. Aliment Pharmacol Ther 24: 859-867
29. James AN et al. (2005) Effects of the selective serotonin reuptake inhibitor, fluoxetine, on regional gastric contractility. Neurogastroenterol Motil 17: 76-82
30. Soo S et al. (2004) A systematic review of psychological therapies for nonulcer dyspepsia. Am J Gastroenterol 99: 1817-1822
31. Calvert EL et al. (2002) Long-term improvement in functional dyspepsia using hypnotherapy. Gastroenterology 123: 1778-1785
32. Mertz H et al. (1998) Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol 93: 160-165